Dosing & Uses
Dosage Forms & Strengths
polymyxin B/bacitracin topical
topical ointment, cream
- (10,000unit/500unit)/g
Treatment/Prophylaxis Superficial Skin Infection
Apply topically qD-TID
Other Information
For gram-pos & gram-neg infections
Good broad spectrum coverage
Does not cause allergic contact dermatitis like neosporin or other neomycin containing topical antibiotic preparations
Dosage Forms & Strengths
polymyxin B/bacitracin topical
topical ointment, cream
- (10,000unit/500unit)/g
Treatment/Prevention Superficial Skin Infection
Apply Topically qD-TID
Other Information
For gram-pos & gram-neg infections
Good broad spectrum coverage
Does not cause allergic contact dermatitis like neosporin or other neomycin containing topical antibiotic preparations
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Adverse Effects
<1%
Allergic contact dermatitis
Warnings
Contraindications
Hypersensitivity
Not for ophthalmic use or over large areas of body
Pregnancy & Lactation
Pregnancy Category: C
Lactation: unknown if distributed in breast milk
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
See individual monograph for further details:
Bacitracin
Mechanism of Action
Antibacterial
